Skip to main content
Top
Published in: Respiratory Research 1/2013

Open Access 01-12-2013 | Research

Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study

Authors: Mikael Andersson, Frode Slinde, Anne Marie Grönberg, Ulla Svantesson, Christer Janson, Margareta Emtner

Published in: Respiratory Research | Issue 1/2013

Login to get access

Abstract

Background

Decreased physical activity is associated with higher mortality in subjects with COPD. The aim of this study was to assess clinical characteristics and physical activity levels (PALs) in subjects with COPD.

Methods

Seventy-three subjects with COPD (67 ± 7 yrs, 44 female) with one-second forced expiratory volume percentage (FEV1%) predicted values of 43 ± 16 were included. The ratio of total energy expenditure (TEE) and resting metabolic rate (RMR) was used to define the physical activity level (PAL) (PAL = TEE/RMR). TEE was assessed with an activity monitor (ActiReg), and RMR was measured by indirect calorimetry. Walking speed (measured over 30-meters), maximal quadriceps muscle strength, fat-free mass and systemic inflammation were measured as clinical characteristics. Hierarchical linear regression was applied to investigate the explanatory values of the clinical correlates to PAL.

Results

The mean PAL was 1.47 ± 0.19, and 92% of subjects were classified as physically very inactive or sedentary. The walking speed was 1.02 ± 0.23 m/s, the quadriceps strength was 31.3 ± 11.2 kg, and the fat-free mass index (FFMI) was 15.7 ± 2.3 kg/m2, identifying 42% of subjects as slow walkers, 21% as muscle-weak and 49% as FFM-depleted. The regression model explained 45.5% (p < 0.001) of the variance in PAL. The FEV1% predicted explained the largest proportion (22.5%), with further improvements in the model from walking speed (10.1%), muscle strength (7.0%) and FFMI (3.0%). Neither age, gender nor systemic inflammation contributed to the model.

Conclusions

Apart from lung function, walking speed and muscle strength are important correlates of physical activity. Further explorations of the longitudinal effects of the factors characterizing the most inactive subjects are warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef
2.
go back to reference Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008, 177: 743-751. 10.1164/rccm.200707-1011OC.PubMedCrossRef Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008, 177: 743-751. 10.1164/rccm.200707-1011OC.PubMedCrossRef
3.
go back to reference Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009, 33: 1165-1185. 10.1183/09031936.00128008.PubMedCrossRef Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009, 33: 1165-1185. 10.1183/09031936.00128008.PubMedCrossRef
4.
go back to reference Laveneziana P, Palange P: Physical activity, nutritional status and systemic inflammation in COPD. Eur Respir J. 2012, 40: 522-529. 10.1183/09031936.00041212.PubMedCrossRef Laveneziana P, Palange P: Physical activity, nutritional status and systemic inflammation in COPD. Eur Respir J. 2012, 40: 522-529. 10.1183/09031936.00041212.PubMedCrossRef
5.
go back to reference Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC, Wouters EFM: Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006, 100: 1349-1355. 10.1016/j.rmed.2005.11.023.PubMedCrossRef Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC, Wouters EFM: Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006, 100: 1349-1355. 10.1016/j.rmed.2005.11.023.PubMedCrossRef
6.
go back to reference Bossenbroek L, de Greef MHG, Wempe JB, Krijnen WP, Ten Hacken NHT: Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD. 2011, 8: 306-319. 10.3109/15412555.2011.578601.PubMedCrossRef Bossenbroek L, de Greef MHG, Wempe JB, Krijnen WP, Ten Hacken NHT: Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD. 2011, 8: 306-319. 10.3109/15412555.2011.578601.PubMedCrossRef
7.
go back to reference Mador MJ, Patel AN, Nadler J: Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011, 31: 52-59. 10.1097/HCR.0b013e3181ebf2ef.PubMedCrossRef Mador MJ, Patel AN, Nadler J: Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011, 31: 52-59. 10.1097/HCR.0b013e3181ebf2ef.PubMedCrossRef
8.
go back to reference Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, Costello RW: Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012, 106: 1671-1679. 10.1016/j.rmed.2012.08.016.PubMedCrossRef Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, Costello RW: Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012, 106: 1671-1679. 10.1016/j.rmed.2012.08.016.PubMedCrossRef
9.
go back to reference Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L, Celli BR: The 6-min walking distance: long-term follow up in patients with COPD. European Respiratory Journal. 2007, 29: 535-540. 10.1183/09031936.00071506.PubMedCrossRef Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L, Celli BR: The 6-min walking distance: long-term follow up in patients with COPD. European Respiratory Journal. 2007, 29: 535-540. 10.1183/09031936.00071506.PubMedCrossRef
10.
go back to reference Waschki B, Kirsten A, Holz O, Müller K-C, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011, 140: 331-342. 10.1378/chest.10-2521.PubMedCrossRef Waschki B, Kirsten A, Holz O, Müller K-C, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011, 140: 331-342. 10.1378/chest.10-2521.PubMedCrossRef
11.
go back to reference Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C: Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012, 142: 338-346. 10.1378/chest.11-2014.PubMedCrossRef Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C: Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012, 142: 338-346. 10.1378/chest.11-2014.PubMedCrossRef
12.
go back to reference Bauman AE, Sallis JF, Dzewaltowski DA, Owen N: Toward a better understanding of the influences on physical activity: The role of determinants, correlates, causal variables, mediators, moderators, and confounders. Am J Prev Med. 2002, 23 (2, Supplement 1): 5-14. 10.1016/S0749-3797(02)00469-5.PubMedCrossRef Bauman AE, Sallis JF, Dzewaltowski DA, Owen N: Toward a better understanding of the influences on physical activity: The role of determinants, correlates, causal variables, mediators, moderators, and confounders. Am J Prev Med. 2002, 23 (2, Supplement 1): 5-14. 10.1016/S0749-3797(02)00469-5.PubMedCrossRef
13.
go back to reference Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJF, Martin BW: Correlates of physical activity: why are some people physically active and others not?. Lancet. 2012, 380: 258-271. 10.1016/S0140-6736(12)60735-1.PubMedCrossRef Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJF, Martin BW: Correlates of physical activity: why are some people physically active and others not?. Lancet. 2012, 380: 258-271. 10.1016/S0140-6736(12)60735-1.PubMedCrossRef
14.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.PubMedCrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.PubMedCrossRef
15.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef
16.
go back to reference Hustvedt B-E, Christophersen A, Johnsen LR, Tomten H, McNeill G, Haggarty P, Løvø A: Description and validation of the ActiReg: a novel instrument to measure physical activity and energy expenditure. Br J Nutr. 2004, 92: 1001-1008. 10.1079/BJN20041272.PubMedCrossRef Hustvedt B-E, Christophersen A, Johnsen LR, Tomten H, McNeill G, Haggarty P, Løvø A: Description and validation of the ActiReg: a novel instrument to measure physical activity and energy expenditure. Br J Nutr. 2004, 92: 1001-1008. 10.1079/BJN20041272.PubMedCrossRef
17.
go back to reference Human energy requirements: Report of a Joint FAO/WHO/UNU Expert Consultation. 2001, Rome Human energy requirements: Report of a Joint FAO/WHO/UNU Expert Consultation. 2001, Rome
18.
go back to reference Arvidsson D, Slinde F, Nordenson A, Larsson S, Hulthén L: Validity of the ActiReg system in assessing energy requirement in chronic obstructive pulmonary disease patients. Clin Nutr. 2006, 25: 68-74. 10.1016/j.clnu.2005.09.001.PubMedCrossRef Arvidsson D, Slinde F, Nordenson A, Larsson S, Hulthén L: Validity of the ActiReg system in assessing energy requirement in chronic obstructive pulmonary disease patients. Clin Nutr. 2006, 25: 68-74. 10.1016/j.clnu.2005.09.001.PubMedCrossRef
19.
go back to reference Andersson M, Moberg L, Svantesson U, Sundbom A, Johansson H, Emtner M: Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test. Prim Care Respir J. 2011, 20: 434-440. 10.4104/pcrj.2011.00082.PubMedCrossRef Andersson M, Moberg L, Svantesson U, Sundbom A, Johansson H, Emtner M: Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test. Prim Care Respir J. 2011, 20: 434-440. 10.4104/pcrj.2011.00082.PubMedCrossRef
20.
go back to reference Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB, Tylavsky FA, Brach JS, Satterfield S, Bauer DC, Visser M, Rubin SM, Harris TB, Pahor M: Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005, 53: 1675-1680. 10.1111/j.1532-5415.2005.53501.x.PubMedCrossRef Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB, Tylavsky FA, Brach JS, Satterfield S, Bauer DC, Visser M, Rubin SM, Harris TB, Pahor M: Prognostic value of usual gait speed in well-functioning older people–results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005, 53: 1675-1680. 10.1111/j.1532-5415.2005.53501.x.PubMedCrossRef
21.
go back to reference Seymour J, Spruit M, Hopkinson N, Natanek S, Man W, Jackson A, Gosker H, Schols A, Moxham J, Polkey M, Wouters E: The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010, 36: 81-88. 10.1183/09031936.00104909.PubMedPubMedCentralCrossRef Seymour J, Spruit M, Hopkinson N, Natanek S, Man W, Jackson A, Gosker H, Schols A, Moxham J, Polkey M, Wouters E: The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010, 36: 81-88. 10.1183/09031936.00104909.PubMedPubMedCentralCrossRef
22.
go back to reference Mahler D, Wells C: Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93: 580-586. 10.1378/chest.93.3.580.PubMedCrossRef Mahler D, Wells C: Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93: 580-586. 10.1378/chest.93.3.580.PubMedCrossRef
23.
go back to reference Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33: 262-272.PubMedCrossRef Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33: 262-272.PubMedCrossRef
24.
go back to reference Jehn M, Schmidt-Trucksäss A, Meyer A, Schindler C, Tamm M, Stolz D: Association of daily physical activity volume and intensity with COPD severity. Respir Med. 2011, 105: 1846-1852. 10.1016/j.rmed.2011.07.003.PubMedCrossRef Jehn M, Schmidt-Trucksäss A, Meyer A, Schindler C, Tamm M, Stolz D: Association of daily physical activity volume and intensity with COPD severity. Respir Med. 2011, 105: 1846-1852. 10.1016/j.rmed.2011.07.003.PubMedCrossRef
25.
go back to reference Pitta F, Troosters T, Probst VS, Lucas S, Decramer M, Gosselink R: Potential consequences for stable chronic obstructive pulmonary disease patients who do not get the recommended minimum daily amount of physical activity. J Bras Pneumol. 2006, 32: 301-308. 10.1590/S1806-37132006000400008.PubMedCrossRef Pitta F, Troosters T, Probst VS, Lucas S, Decramer M, Gosselink R: Potential consequences for stable chronic obstructive pulmonary disease patients who do not get the recommended minimum daily amount of physical activity. J Bras Pneumol. 2006, 32: 301-308. 10.1590/S1806-37132006000400008.PubMedCrossRef
26.
go back to reference Walker PP, Burnett A, Flavahan PW, Calverley PMA: Lower limb activity and its determinants in COPD. Thorax. 2008, 63: 683-689. 10.1136/thx.2007.087130.PubMedCrossRef Walker PP, Burnett A, Flavahan PW, Calverley PMA: Lower limb activity and its determinants in COPD. Thorax. 2008, 63: 683-689. 10.1136/thx.2007.087130.PubMedCrossRef
27.
go back to reference Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-Collazo E, Alvarez-Sala R: Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009, 180: 506-512. 10.1164/rccm.200812-1873OC.PubMedCrossRef Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-Collazo E, Alvarez-Sala R: Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009, 180: 506-512. 10.1164/rccm.200812-1873OC.PubMedCrossRef
28.
go back to reference Thomas M, Decramer M, O’Donnell DE: No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J. 2013, 22: 101-111. 10.4104/pcrj.2013.00025.PubMedCrossRef Thomas M, Decramer M, O’Donnell DE: No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J. 2013, 22: 101-111. 10.4104/pcrj.2013.00025.PubMedCrossRef
29.
go back to reference Polkey MI, Moxham J: Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med. 2006, 6: 190-196. 10.7861/clinmedicine.6-2-190.CrossRef Polkey MI, Moxham J: Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med. 2006, 6: 190-196. 10.7861/clinmedicine.6-2-190.CrossRef
30.
go back to reference Belza B, Steele BG, Hunziker J, Lakshminaryan S, Holt L, Buchner DM: Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res. 2001, 50: 195-202. 10.1097/00006199-200107000-00003.PubMedCrossRef Belza B, Steele BG, Hunziker J, Lakshminaryan S, Holt L, Buchner DM: Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res. 2001, 50: 195-202. 10.1097/00006199-200107000-00003.PubMedCrossRef
31.
go back to reference Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R: Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005, 171: 972-977. 10.1164/rccm.200407-855OC.PubMedCrossRef Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R: Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005, 171: 972-977. 10.1164/rccm.200407-855OC.PubMedCrossRef
32.
go back to reference DePew ZS, Karpman C, Novotny PJ, Benzo RP: Correlations between gait speed, six-minute walk, physical activity, and self-efficacy in severe chronic lung disease. Respir Care. 2013 DePew ZS, Karpman C, Novotny PJ, Benzo RP: Correlations between gait speed, six-minute walk, physical activity, and self-efficacy in severe chronic lung disease. Respir Care. 2013
33.
go back to reference Kon SS, Patel MS, Canavan JL, Clark AL, Jones SE, Nolan CM, Cullinan P, Polkey MI, Man WD-C: Reliability and validity of the four metre gait speed in COPD. Eur Respir J. 2012 Kon SS, Patel MS, Canavan JL, Clark AL, Jones SE, Nolan CM, Cullinan P, Polkey MI, Man WD-C: Reliability and validity of the four metre gait speed in COPD. Eur Respir J. 2012
34.
go back to reference Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J: Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004, 24: 129-136. 10.1183/09031936.04.00079603.PubMedCrossRef Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J: Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004, 24: 129-136. 10.1183/09031936.04.00079603.PubMedCrossRef
35.
go back to reference van den Borst B, Slot IGM, Hellwig VACV, Vosse BAH, Kelders MCJM, Barreiro E, Schols AMWJ, Gosker HR: Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2013, 114: 1319-1328. 10.1152/japplphysiol.00508.2012.PubMedCrossRef van den Borst B, Slot IGM, Hellwig VACV, Vosse BAH, Kelders MCJM, Barreiro E, Schols AMWJ, Gosker HR: Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2013, 114: 1319-1328. 10.1152/japplphysiol.00508.2012.PubMedCrossRef
36.
go back to reference Remoortel HV, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T: Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013 Remoortel HV, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T: Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013
37.
go back to reference Decramer M, Lacquet LM, Fagard R, Rogiers P: Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994, 150: 11-16. 10.1164/ajrccm.150.1.8025735.PubMedCrossRef Decramer M, Lacquet LM, Fagard R, Rogiers P: Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994, 150: 11-16. 10.1164/ajrccm.150.1.8025735.PubMedCrossRef
38.
go back to reference Eagan TML, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD: Body composition and plasma levels of inflammatory biomarkers in COPD. Eur Respir J. 2010, 36: 1027-1033. 10.1183/09031936.00194209.PubMedCrossRef Eagan TML, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD: Body composition and plasma levels of inflammatory biomarkers in COPD. Eur Respir J. 2010, 36: 1027-1033. 10.1183/09031936.00194209.PubMedCrossRef
39.
go back to reference Evans RA, Hill K, Dolmage TE, Blouin M, O’Hoski S, Brooks D, Goldstein RS: Properties of self-paced walking in chronic respiratory disease: A patient goal-oriented assessment. Chest. 2011, 140: 737-743. 10.1378/chest.10-3104.PubMedCrossRef Evans RA, Hill K, Dolmage TE, Blouin M, O’Hoski S, Brooks D, Goldstein RS: Properties of self-paced walking in chronic respiratory disease: A patient goal-oriented assessment. Chest. 2011, 140: 737-743. 10.1378/chest.10-3104.PubMedCrossRef
40.
go back to reference Dolmage TE, Evans RA, Hill K, Blouin M, Brooks D, Goldstein RS: The effect of pulmonary rehabilitation on critical walk speed in patients with COPD: a comparison with self-paced walks. Chest. 2012, 141: 413-419. 10.1378/chest.11-1059.PubMedCrossRef Dolmage TE, Evans RA, Hill K, Blouin M, Brooks D, Goldstein RS: The effect of pulmonary rehabilitation on critical walk speed in patients with COPD: a comparison with self-paced walks. Chest. 2012, 141: 413-419. 10.1378/chest.11-1059.PubMedCrossRef
41.
go back to reference Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R: Are patients with COPD more active after pulmonary rehabilitation?. Chest. 2008, 134: 273-280. 10.1378/chest.07-2655.PubMedCrossRef Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R: Are patients with COPD more active after pulmonary rehabilitation?. Chest. 2008, 134: 273-280. 10.1378/chest.07-2655.PubMedCrossRef
Metadata
Title
Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study
Authors
Mikael Andersson
Frode Slinde
Anne Marie Grönberg
Ulla Svantesson
Christer Janson
Margareta Emtner
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2013
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-14-128

Other articles of this Issue 1/2013

Respiratory Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.